Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.58 $13,428 - $24,387
15,435 New
15,435 $13,000
Q2 2020

Aug 14, 2020

SELL
$16.6 - $25.25 $177,238 - $269,594
-10,677 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$14.38 - $27.72 $153,535 - $295,966
10,677 New
10,677 $205,000
Q4 2018

Feb 14, 2019

SELL
$8.2 - $16.95 $182,581 - $377,408
-22,266 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$17.03 - $21.18 $379,189 - $471,593
22,266 New
22,266 $379,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $54.3M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.